REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 4 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13,285,388 | +11.2% | 130,300 | -0.8% | 0.04% | 0.0% |
| Q1 2023 | $11,946,888 | +1027.1% | 131,400 | +371.0% | 0.04% | +2050.0% |
| Q4 2022 | $1,059,921 | -70.1% | 27,900 | -80.2% | 0.00% | -71.4% |
| Q3 2022 | $3,546,000 | +1213.3% | 141,100 | +1485.4% | 0.01% | – |
| Q2 2022 | $270,000 | -80.6% | 8,900 | -79.1% | 0.00% | -100.0% |
| Q1 2022 | $1,392,000 | +173.5% | 42,500 | +120.2% | 0.00% | – |
| Q4 2021 | $509,000 | -89.5% | 19,300 | -60.0% | 0.00% | -100.0% |
| Q3 2021 | $4,859,000 | -36.3% | 48,300 | -10.4% | 0.01% | -44.4% |
| Q2 2021 | $7,628,000 | +302.7% | 53,900 | +183.7% | 0.01% | +200.0% |
| Q1 2021 | $1,894,000 | +1606.3% | 19,000 | +2011.1% | 0.00% | – |
| Q4 2020 | $111,000 | -45.9% | 900 | -57.1% | 0.00% | -100.0% |
| Q3 2020 | $205,000 | -88.6% | 2,100 | -81.7% | 0.00% | -87.5% |
| Q2 2020 | $1,794,000 | -77.7% | 11,500 | -79.4% | 0.01% | -87.7% |
| Q1 2020 | $8,054,000 | +125.1% | 55,800 | +218.9% | 0.06% | +170.8% |
| Q4 2019 | $3,578,000 | +11081.2% | 17,500 | +4275.0% | 0.02% | – |
| Q3 2019 | $32,000 | -82.2% | 400 | -87.5% | 0.00% | -100.0% |
| Q4 2018 | $180,000 | -33.3% | 3,200 | -3.0% | 0.00% | 0.0% |
| Q3 2018 | $270,000 | +6650.0% | 3,300 | +1550.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 131,400 | $11,946,888 | 0.04% |
| SIMPLEX TRADING, LLC | 94,300 | $8,573 | 0.01% |
| JANE STREET GROUP, LLC | 97,400 | $8,855,608 | 0.00% |
| JPMORGAN CHASE & CO | 310,000 | $28,185,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |